Congratulations Andrew Forbes - ATACAS named 2017 Trial of the Year

At the recent ACTA awards, Trial of the Year was awarded to the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial which was run by Paul Myles, a member of the ViCBiostat advisory board with Andrew Forbes being the trial statistician and a co-investigator.  The ATACAS trial explored the risks associated with aspirin and tranexamic acid before and after open heart surgery and involved over 4,600 participants in 31 hospitals across 7 countries.